Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00283348 · ClinicalTrials.gov registry record
New Strategies for Non-invasive Detection of Chronic Allograft Nephropathy
A clinical trial of Chronic Rejection, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 121
- Enrollment target
- 1
- Study location
NCT00283348 is a study of Chronic Rejection that has completed, run by Virginia Commonwealth University. The registered enrollment target is 121 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00283348, a study of Chronic Rejection, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 121 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to help researchers find out more about a condition called "Chronic Allograft Nephropathy" (CAN). CAN is a complication that sometimes occurs after kidney transplantation and affects the function of the transplanted kidney. It is hoped that by studying blood, urine, and tissue samples of kidney transplant patients, new ways of diagnosing and treating CAN may be found.
Conditions Studied
Study Locations (1)
Virginia
- VCU Health System - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00283348
The ClinicalTrials.gov registry entry for NCT00283348 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Rejection appearing as the primary indexed condition, and to 0 interventions.
NCT00283348 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT00283348 about?
NCT00283348 is a clinical study titled "New Strategies for Non-invasive Detection of Chronic Allograft Nephropathy". The purpose of this study is to help researchers find out more about a condition called "Chronic Allograft Nephropathy" (CAN). CAN is a complication that sometimes occurs after kidney transplantation and affects the function of the transplanted kidney. It is hoped that by studying blood, urine, and ...
What is the current status of trial NCT00283348?
This trial is currently completed. The enrollment target is 121 participants. The study started on 2006-01. Estimated completion is 2008-12.
What conditions does trial NCT00283348 study?
This clinical trial studies the following conditions: Chronic Rejection.
Who is sponsoring clinical trial NCT00283348?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00283348 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.